Selection of full-length IgGs by tandem display on filamentous phage particles and Escherichia coli fluorescence-activated cell sorting screening

FEBS Journal

Volumn 277, Issue 10, 2010, Pages 2291-2303

  Mazor, Yariv ^a,b   Van Blarcom, Thomas ^a,b   Carroll, Sean ^a,b   Georgiou, George ^a,b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b The University of Texas at Austin   (United States)

Author keywords

Fluorescence activated cell sorting (FACS); Full length IgG; FUSE5 ZZ phage; Protective antigen (PA); Spheroplasts

Indexed keywords

COAT PROTEIN; FC RECEPTOR; IMMUNOGLOBULIN G;

ANTIBODY LIBRARY; ANTIBODY SCREENING; ARTICLE; ESCHERICHIA COLI; FLUORESCENCE ACTIVATED CELL SORTING; NONHUMAN; PHAGE DISPLAY; PHAGEMID; PRIORITY JOURNAL; PROCESS MONITORING; PROCESS OPTIMIZATION; PROTEIN BINDING;

ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; BACTERIOPHAGES; CAPSID PROTEINS; DIGOXIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLOW CYTOMETRY; GENETIC VECTORS; IMMUNOGLOBULIN G; KINETICS; PEPTIDE LIBRARY; RECOMBINANT PROTEINS; SPHEROPLASTS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 77951735683     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07645.x     Document Type: Article

References (61)

1. Imai K Takaoka A (2006) Comparing antibody and small-molecule therapies for cancer. Nat Rev Cancer 6, 714 727.
2. Jefferis R Lund J (2002) Interaction sites on human IgG-Fc for FcgammaR: current models. Immunol Lett 82, 57 65.
3. Hoogenboom HR (2005) Selecting and screening recombinant antibody libraries. Nat Biotechnol 23, 1105 1116.
4. Moulard M et al. (2002) Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes. Proc Natl Acad Sci USA 99, 6913 6918.
5. Kramer RA et al. (2005) The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries. Eur J Immunol 35, 2131 2145.
6. Clackson T, Hoogenboom HR, Griffiths AD Winter G (1991) Making antibody fragments using phage display libraries. Nature 352, 624 628.
7. Barbas CF III., Kang AS, Lerner RA Benkovic SJ (1991) Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci USA 88, 7978 7982.
8. Marks JD et al. (1991) By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 222, 581 597.
9. Sheets MD et al. (1998) Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. Proc Natl Acad Sci USA 95, 6157 6162.
10. Nissim A et al. (1994) Antibody fragments from a 'single pot' phage display library as immunochemical reagents. EMBO J 13, 692 698.
11. Vaughan TJ et al. (1996) Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat Biotechnol 14, 309 314.
12. de Haard HJ et al. (1999) A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J Biol Chem 274, 18218 18230.
13. Souriau C Hudson PJ (2003) Recombinant antibodies for cancer diagnosis and therapy. Expert Opin Biol Ther 3, 305 318.
14. Sidhu SS et al. (2004) Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions. J Mol Biol 338, 299 310.
15. de Kruif J, Boel E Logtenberg T (1995) Selection and application of human single chain Fv antibody fragments from a semi-synthetic phage antibody display library with designed CDR3 regions. J Mol Biol 248, 97 105.
16. Hoet RM et al. (2005) Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity. Nat Biotechnol 23, 344 348.
17. Knappik A et al. (2000) Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J Mol Biol 296, 57 86.
18. Griffiths AD et al. (1994) Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J 13, 3245 3260.
19. Rauchenberger R et al. (2003) Human combinatorial Fab library yielding specific and functional antibodies against the human fibroblast growth factor receptor 3. J Biol Chem 278, 38194 38205.
20. Fellouse FA et al. (2007) High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries. J Mol Biol 373, 924 940.
21. Rothe C et al. (2008) The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies. J Mol Biol 376, 1182 1200.
22. Schier R et al. (1996) Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection. J Mol Biol 255, 28 43.
23. Schier R et al. (1996) Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site. J Mol Biol 263, 551 567.
24. Thompson J et al. (1996) Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity. J Mol Biol 256, 77 88.
25. Yang WP et al. (1995) CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J Mol Biol 254, 392 403.
26. Lu D et al. (2003) Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity. J Biol Chem 278, 43496 43507. (Pubitemid 37345973)
27. Jespers LS, Roberts A, Mahler SM, Winter G Hoogenboom HR (1994) Guiding the selection of human antibodies from phage display repertoires to a single epitope of an antigen. Bio/technology 12, 899 903.
28. Osbourn J, Groves M Vaughan T (2005) From rodent reagents to human therapeutics using antibody guided selection. Methods 36, 61 68.
29. Reichert JM, Rosensweig CJ, Faden LB Dewitz MC (2005) Monoclonal antibody successes in the clinic. Nat Biotechnol 23, 1073 1078.
30. Walsh G (2006) Biopharmaceutical benchmarks 2006. Nat Biotechnol 24, 769 776.
31. McCafferty J, Griffiths AD, Winter G Chiswell DJ (1990) Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348, 552 554.
32. Hoogenboom HR et al. (1991) Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res 19, 4133 4137.
33. Milenic DE et al. (1991) Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Res 51, 6363 6371.
34. Pini A Bracci L (2000) Phage display of antibody fragments. Curr Protein Pept Sci 1, 155 169.
35. Worn A Pluckthun A (2001) Stability engineering of antibody single-chain Fv fragments. J Mol Biol 305, 989 1010.
36. Lee CV, Sidhu SS Fuh G (2004) Bivalent antibody phage display mimics natural immunoglobulin. J Immunol Methods 284, 119 132.
37. O'Connell D, Becerril B, Roy-Burman A, Daws M Marks JD (2002) Phage versus phagemid libraries for generation of human monoclonal antibodies. J Mol Biol 321, 49 56.
38. Hayhurst A et al. (2003) Isolation and expression of recombinant antibody fragments to the biological warfare pathogen Brucella melitensis. J Immunol Methods 276, 185 196.
39. Mazor Y, Blarcom TV, Mabry R, Iverson BL Georgiou G (2007) Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli. Nat Biotechnol 25, 563 565.
40. Mazor Y, Van Blarcom T, Iverson BL Georgiou G (2008) E-clonal antibodies: selection of full-length IgG antibodies using bacterial periplasmic display. Nat Protoc 3, 1766 1777.
41. Georgiou G (2000) Analysis of large libraries of protein mutants using flow cytometry. Adv Protein Chem 55, 293 315.
42. Daugherty PS (2007) Protein engineering with bacterial display. Curr Opin Struct Biol 17, 474 480.
43. Chao G et al. (2006) Isolating and engineering human antibodies using yeast surface display. Nat Protoc 1, 755 768.
44. Yacoby I, Shamis M, Bar H, Shabat D Benhar I (2006) Targeting antibacterial agents by using drug-carrying filamentous bacteriophages. Antimicrob Agents Chemother 50, 2087 2097.
45. Nilsson B et al. (1987) A synthetic IgG-binding domain based on staphylococcal protein A. Protein Eng 1, 107 113.
46. Junutula JR et al. (2008) Rapid identification of reactive cysteine residues for site-specific labeling of antibody-Fabs. J Immunol Methods 332, 41 52.
47. Skerra A Pluckthun A (1988) Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 240, 1038 1041.
48. Bradbury AR Marks JD (2004) Antibodies from phage antibody libraries. J Immunol Methods 290, 29 49.
49. Weidner KM, Denzin LK Voss EW Jr. (1992) Molecular stabilization effects of interactions between anti-metatype antibodies and liganded antibody. J Biol Chem 267, 10281 10288.
50. Holliger P, Prospero T Winter G (1993) 'Diabodies': small bivalent and bispecific antibody fragments. Proc Natl Acad Sci USA 90, 6444 6448.
51. Kortt AA et al. (1997) Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimer. Protein Eng 10, 423 433.
52. Better M, Chang CP, Robinson RR Horwitz AH (1988) Escherichia coli secretion of an active chimeric antibody fragment. Science 240, 1041 1043.
53. Horwitz AH, Chang CP, Better M, Hellstrom KE Robinson RR (1988) Secretion of functional antibody and Fab fragment from yeast cells. Proc Natl Acad Sci USA 85, 8678 8682.
54. Baca M, Presta LG, O'Connor SJ Wells JA (1997) Antibody humanization using monovalent phage display. J Biol Chem 272, 10678 10684.
55. Chen Y et al. (1999) Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen. J Mol Biol 293, 865 881.
56. Liang WC et al. (2007) Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library. J Mol Biol 366, 815 829.
57. Wu Y et al. (2007) Structural insight into distinct mechanisms of protease inhibition by antibodies. Proc Natl Acad Sci USA 104, 19784 19789.
58. Becerril B, Poul MA Marks JD (1999) Toward selection of internalizing antibodies from phage libraries. Biochem Biophys Res Commun 255, 386 393.
59. Smith GP Scott JK (1993) Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol 217, 228 257.
60. Ribnicky B, Van Blarcom T Georgiou G (2007) A scFv antibody mutant isolated in a genetic screen for improved export via the twin arginine transporter pathway exhibits faster folding. J Mol Biol 369, 631 639.
61. Chames P, Hoogenboom HR Henderikx P (2002) Selection of antibodies against biotinylated antigens. Methods Mol Biol 178, 147 157.